ABC.L Regulatory News (ABC)

18 Jun 2007 07:01

ABCAM Plc18 June 2007 For immediate release 18 June 2007 ABCAM PLC ("Abcam" or "the Company") Presentation at Piper Jaffray's Second Annual London Health Care Conference on 21 June 2007 Cambridge UK, 18 June 2007: Abcam plc (AIM: ABC), the rapidly growing biosciencecompany that markets antibodies via its own online catalogue, today announcesthat Mark Webster, Abcam's Commercial Director, will present at Piper Jaffray'sSecond Annual London Health Care Conference on 21 June at 12:00pm. Theconference will be held at the Great Eastern Hotel, 40 Liverpool St, London,EC2M 7QN. For further information please contact: Abcam + 44 (0) 1223 696000Jonathan Milner, Chief Executive OfficerEddie Powell, Chief Financial Officerwww.abcam.com Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts. Abcamwas admitted to AIM in November 2005 and trades under the ticker symbol ABC.The Company produces and distributes its own and third party produced antibodiesto academic and commercial users throughout the world with product informationprovided and ordering available through the Company's website, www.abcam.com.The antibodies are sold under the Abcam brand name. The Company's vision is tobuild the largest online antibody resource in the world while also ensuring thatthe antibodies are of high quality and commercially viable. Abcam now has anonline catalogue of approximately 29,000 products, most of which are antibodies,from over 200 suppliers supported by up-to-date and detailed technical datasheets, which are created by the Company. The Company currently employs 120staff in its three operating companies. This information is provided by RNS The company news service from the London Stock Exchange